US Capitol Capsule: What to do about inter partes reviews? Reforming reforms
This article was originally published in Scrip
Executive Summary
With 4th of July vacations over, the trade groups representing the biopharmaceutical industry are gearing up for their next big fight in Washington – changing the path of a patent reform bill, The Innovation Act (HR 9), which is expected to be voted on this month by the US House.